Drug recall · May 22, 2024
Losartan Potassium and Hydrochlorothiazide Tablets recall
Why: Presence of foreign substance: plastic-like substance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
- Lots / codes
Lot #: BLK2304A, Exp. 07/31/2025
- Quantity
- 1,048 bottles
- Company
- Macleods Pharma USA, Inc, Princeton, NJ
- Distribution
- USA Nationwide
- Initiated
- May 7, 2024 · Voluntary: Firm initiated
- Classified
- May 15, 2024
- Reported
- May 22, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.